| Histone modifications drive aberrant Notch3 expression/activity and growth in T-ALL L Tottone, N Zhdanovskaya, Á Carmona Pestaña, M Zampieri, F Simeoni, ... Frontiers in oncology 9, 198, 2019 | 39 | 2019 |
| Targeting notch to maximize chemotherapeutic benefits: Rationale, advanced strategies, and future perspectives N Zhdanovskaya, M Firrincieli, S Lazzari, E Pace, P Scribani Rossi, ... Cancers 13 (20), 5106, 2021 | 23 | 2021 |
| MicroRNAs as modulators of the immune response in T-cell acute lymphoblastic leukemia M Del Gaizo, I Sergio, S Lazzari, S Cialfi, M Pelullo, I Screpanti, MP Felli International Journal of Molecular Sciences 23 (2), 829, 2022 | 9 | 2022 |
| Identification of a novel curcumin derivative influencing notch pathway and DNA damage as a potential therapeutic agent in T-ALL N Zhdanovskaya, S Lazzari, D Caprioglio, M Firrincieli, C Maioli, E Pace, ... Cancers 14 (23), 5772, 2022 | 2 | 2022 |
